![James M. Wilson | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania James M. Wilson | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania](https://www.med.upenn.edu/apps/my/images/faculty_pics/wils7199.jpg)
James M. Wilson | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania
![The doctor responsible for gene therapy's greatest setback is sounding a new alarm | MIT Technology Review The doctor responsible for gene therapy's greatest setback is sounding a new alarm | MIT Technology Review](https://wp.technologyreview.com/wp-content/uploads/2018/01/wilson-james-lab-shot-7.jpg)
The doctor responsible for gene therapy's greatest setback is sounding a new alarm | MIT Technology Review
![Gene Therapy Startup Partnered with Jim Wilson's U Penn Program Nets $65M | Inside Precision Medicine Gene Therapy Startup Partnered with Jim Wilson's U Penn Program Nets $65M | Inside Precision Medicine](https://www.insideprecisionmedicine.com/wp-content/uploads/2021/07/GeneEditing_GettyImages_930103248_CIPhotos_GlovedHandsDNA-696x464.jpg)
Gene Therapy Startup Partnered with Jim Wilson's U Penn Program Nets $65M | Inside Precision Medicine
![Penn Medicine News on X: "Dr. James Wilson's deal with @amicusrx1 is named Deal of the Year. It formed a collaboration between Amicus and @PennMedicine's gene therapy program #PennInnovators2018 https://t.co/TBmlTXZV1N" / X Penn Medicine News on X: "Dr. James Wilson's deal with @amicusrx1 is named Deal of the Year. It formed a collaboration between Amicus and @PennMedicine's gene therapy program #PennInnovators2018 https://t.co/TBmlTXZV1N" / X](https://pbs.twimg.com/media/DtIBqxkU4AErAGR.jpg:large)
Penn Medicine News on X: "Dr. James Wilson's deal with @amicusrx1 is named Deal of the Year. It formed a collaboration between Amicus and @PennMedicine's gene therapy program #PennInnovators2018 https://t.co/TBmlTXZV1N" / X
![Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders | Science Advances Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders | Science Advances](https://www.science.org/cms/10.1126/sciadv.abn4704/asset/d7fc7239-69c2-4ba6-8ed1-3067560a3e23/assets/images/large/sciadv.abn4704-f1.jpg)
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders | Science Advances
![Gene therapy pioneer Dr. James Wilson on what's next for the industry - Philadelphia Business Journal Gene therapy pioneer Dr. James Wilson on what's next for the industry - Philadelphia Business Journal](https://media.bizj.us/view/img/12340345/james-wilson-event-1*1200xx3200-1803-376-240.jpg)
Gene therapy pioneer Dr. James Wilson on what's next for the industry - Philadelphia Business Journal
![Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors: Molecular Therapy - Methods & Clinical Development Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/asset/7faa1075-5959-4778-9eb5-6f7a13451217/fx1.jpg)
Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors: Molecular Therapy - Methods & Clinical Development
![Patrick Hsu on X: "Jim Wilson's lab shows AAV silencing in primate liver. Cells don't like long term transgene expression, even if it's therapeutic! How can we get the epigenome to eat Patrick Hsu on X: "Jim Wilson's lab shows AAV silencing in primate liver. Cells don't like long term transgene expression, even if it's therapeutic! How can we get the epigenome to eat](https://pbs.twimg.com/media/FQLapSnVgAAqHI3.png)